(Q45206602)

10 December 2017

title

Pathology of experimental SARS coronavirus infection in cats and ferrets (English)

1 reference

10 December 2017

0 references

1 reference

1 reference

6

A D M E Osterhaus

1 reference

10 December 2017

J M A van den Brand

1

1 reference

10 December 2017

B L Haagmans

2

1 reference

10 December 2017

L Leijten

3

1 reference

10 December 2017

D van Riel

4

1 reference

10 December 2017

B E E Martina

5

1 reference

10 December 2017

T Kuiken

7

1 reference

10 December 2017

publication date

1 July 2008

1 reference

10 December 2017

1 reference

10 December 2017

volume

45

1 reference

10 December 2017

issue

4

1 reference

10 December 2017

page(s)

551-562

1 reference

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

The clinical pathology of severe acute respiratory syndrome (SARS): a report from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Aetiology: Koch's postulates fulfilled for SARS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Multiple organ infection and the pathogenesis of SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Pathology and pathogenesis of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Bats are natural reservoirs of SARS-like coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Virology: SARS virus infection of cats and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Lung pathology of fatal severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

The severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Is there an ideal animal model for SARS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Molecular pathology in the lungs of severe acute respiratory syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

Identification of ferret ACE2 and its receptor function for SARS-coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.45-4-551

21 January 2018

Identifiers

DOI

10.1354/VP.45-4-551

1 reference

10 December 2017

1 reference